Galina Reshedko

4.0k citations
7 papers · 129 indexed · h-index 5

Galina Reshedko

7 papers receiving 124 citations

Peers

Galina Reshedko
Comparison fields: 5 of 33
  • Molecular Medicine 72
  • Applied Microbiology and Biotechnology 29
  • Endocrinology 20
  • Microbiology 18
  • Pharmacology 45
Replace María Muñoz‐Algarra with:
María Muñoz‐Algarra Spain
Lih-Shinn Wang Taiwan
Xiaoju Lv China
Carlos Bergallo Argentina
Amaia Aguirre-Quiñonero Spain
Giulia Errico Italy
Omar Elahmer Libya
Charatdao Bunthi Thailand
Ahmad Nusair United States
Xinqian Ma China
Galina Reshedko relative to María Muñoz‐Algarra Spain María Muñoz‐Algarra's profile →
Citations per field
00.5×1.7×
María Muñoz‐Algarra · 1×
Citations per year

Countries citing papers authored by Galina Reshedko

Since Specialization
Citations

This map shows the geographic impact of Galina Reshedko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galina Reshedko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galina Reshedko more than expected).

Fields of papers citing papers by Galina Reshedko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galina Reshedko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galina Reshedko. The network helps show where Galina Reshedko may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Galina Reshedko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Galina Reshedko Line = papers co-authored together Galina Reshedko links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1 20182
2 20161
3 200883
4 20054
5 20015
6 20006
7 200028

About Galina Reshedko

Galina Reshedko is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 7 papers that have together received 129 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (4 papers), Antibiotic Resistance in Bacteria (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Antibiotic Use and Resistance (2 papers), Antibiotics Pharmacokinetics and Efficacy (1 paper), Tuberculosis Research and Epidemiology (1 paper), Respiratory Support and Mechanisms (1 paper) and Microscopic Colitis (1 paper). The work is most often cited by research in Molecular Medicine (72 citations), Applied Microbiology and Biotechnology (29 citations) and Endocrinology (20 citations). Galina Reshedko has collaborated with scholars based in Russia, United States and Slovakia. Frequent co-authors include Remus Orăsan, Timothy Babinchak, Gary Dukart, Nathalie Dartois, Jüri Teras, Angel Cooper, Krasimir Vasilev, Evelyn J. Ellis‐Grosse, Miguel Sánchez and Hassan Gandjini. Their work appears in journals such as The Pediatric Infectious Disease Journal, Clinical Microbiology and Infection, International Journal of Antimicrobial Agents, Journal of Antimicrobial Chemotherapy and Tuberculosis and lung diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026